Tyra Biosciences, Inc. Common Stock (TYRA) Stock Price, Quote & AI Analysis

Live TYRA stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Tyra Biosciences, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Tyra Biosciences, Inc. Common Stock (TYRA), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

TYRA
Tyra Biosciences, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
30.650000
High
31.390000
Low
30.355000
Volume
143,119
VWAP
-
Market Cap
$1,644,928,060.36
52W Range
$6.42 - $32.44
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 25, 2026 Q4
After Hours
EPS Estimate: $-0.5497
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Tyra Biosciences, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Tyra Biosciences, Inc. Common Stock Overview

Company information

Company Overview

Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.

Company Details
Market Cap
$1.63B
Shares Outstanding
53,372,096
Weighted Shares Outstanding
53,372,098
CEO
Todd J. Harris
Address
2656 STATE STREET, CARLSBAD, CA, 92008
Employees
60
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Tyra Biosciences, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...